Organization
UCB Pharma, Brussels, Belgium
6 abstracts
Abstract
A NEW ELECTROMECHANICAL PLATFORM FOR SUBCUTANEOUS DRUG DELIVERY: RESULTS FROM AN EU USABILITY STUDY Org: UCB Pharma, Brussels, Belgium,
Abstract
Anti-tnf treatments for women with chronic inflammatory diseases: comparing attitudes and perceptions of physicians in europe and the usOrg: Università degli Studi di Brescia, Brescia, Italy, Botnar Research Centre, Oxford, United Kingdom, Rheumatology & Hiller Research Unit, University Hospital, Düsseldorf, Germany, UCB Pharma, Brussels, Belgium, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States of America,
Abstract
A SURVEY ON PATIENT AND PHYSICIAN PERSPECTIVES ON FAMILY PLANNING AND PREGNANCY ISSUES – DOES CONDITION MATTER? Org: UCB Pharma, Brussels, Belgium, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, Oklahoma Medical Research Foundation, Oklahoma City, United States, Duke University Medical Center, Durham, United States,
Abstract
AN ASSESSMENT OF IMPAIRMENT OF PRODUCTIVITY AMONG SLE PATIENTS Org: UCB Pharma, Brussels, Belgium, Adelphi Real World, Cheshire, United Kingdom,
Abstract
A RANDOMIZED DOUBLE-BLIND TREATMENT STRATEGY STUDY EVALUATING CONTINUATION OR REDUCED-FREQUENCY DOSING OF CERTOLIZUMAB PEGOL VERSUS WITHDRAWAL TO MAINTAIN LOW DISEASE ACTIVITY IN EARLY RA PATIENTS (C-EARLY PERIOD 2) Org: Weill Cornell College, New York, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, UCB Pharma, Raleigh, United States, UCB Pharma, Brussels, Belgium,